The Cardio-Oncology Checklist: Managing Anthracycline and Trastuzumab Toxicity

14 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Managing the cardiotoxic effects of Anthracyclines (e.g., Doxorubicin) and Trastuzumab is a cornerstone of modern cardio-oncology. While both can lead to heart failure, their mechanisms and "reversibility" profiles differ significantly. Here is a clinical checklist for managing these toxicities. Read More: https://johnsonfrancis.org/professional/the-cardio-oncology-checklist-managing-anthracycline-and-trastuzumab-toxicity/
Categoria
Oncology
Commenta per primo questo video.

Prossimo